Company

Granules India Receives An Accreditation Certificate From Japan Brazilian Drug Regulators

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Categories

All Quarterly Result Economy Mutual Fund Business Company Market Budget IPO

Granules India receives an accreditation certificate from Japan, Brazilian drug regulators

Aug 25, 2023

By: BlinkX Research Team

A pharmaceutical company, Granules India, announced gaining an accreditation certificate from the Pharmaceuticals and Medical Devices Agency (PMDA), a Japanese organization, and compliance approval from ANVISA, the Brazilian health regulator.

The company's Jeedimetla plant in Telangana received the accreditation certificate, which is necessary for international pharmaceutical companies to sell medicines to Japan.

“The certification has been received for accreditation categories of non-sterile drugs, packaging, labeling, and storage of drugs,” the company said.

For its Bonthapally facility in Telangana, the company gained approval from the Brazilian regulator for complying with good manufacturing practices guidelines. Active pharmaceutical ingredients (APIs) are produced by a facility.

Pharmaceutical raw materials are produced by Granules India. The company specializes in finished dosages, pharmaceutical formulation intermediates, and active pharmaceutical components.

Source: Media Reports